Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04402541
Recruitment Status : Recruiting
First Posted : May 27, 2020
Last Update Posted : May 18, 2021
Sponsor:
Information provided by (Responsible Party):
Cleave Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 2022
Estimated Study Completion Date : July 2022